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Statement of the Problem 
This proposal was originally designed to determine whether the level of a 
physicians' medical training would affect their intent to vaccinate infants for influenza. 
Why is this important? 
Influenza epidemics occur annually in the winter and cause significant economic 
loss, disease and death, especially among certain high risk populations (principi and 
Esposito, 2004). Infants 6-23 months are one group that is severely affected by influenza 
infection. Moreover, influenza infection of infants and children has been shown to drive 
infections into other segments of the population during an epidemic (Harper et ai, 2004). 
Immunization has been shown to be effective in reducing morbidity and mortality 
due to influenza (Harper et ai, 2004; Munoz, 2003). For that reason, in 2003 the Advisory 
Committee on Immunization Ffactices (ACIP) included infants 6-23 month of age as a 
target population for annual influenza vaccination (Bridges et ai, 2003). It is hoped that 
vaccination of this target popUlation will reduce infection related morbidity and mortality. 
It is also hoped that immunization will decrease spread of infection to other segments of 
the population, especially high risk groups. 
Designation of a new target group presents some significant issues regarding 
successful vaccine utilization. Barriers to vaccination can result from physician factors, 
patient/parent related issues, economic factors or logistical issues. Studies in all areas of 
immunization have identified health care provider-related factors as pivotal to vaccine 
utilization (peckham et ai, 1986; Taylor et ai, 1997; Zimmerman et ai, 1997). 
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Understanding the role of physician training in their intent to vaccinate for influenza 
might lead to strategies that will improve vaccine rates in the 6-23 month old age group. 
Objective of the Proposal 
This proposal examined the effect of the medical level of training of physicians on 
their intent to vaccinate 6-23 month old infants. The purpose was to examine whether 
there is a direct or indirect relationship of the physician level of training to vaccine 
utilization. Knowledge of influenza, the nature of the physician's medical practice and 
attitudes towards immunization influence were also examined. 
The main hypothesis of this proposal was that the level of physician medical training 
directly affects their intent to vaccinate 6-23 month old infants for influenza. This 
relationship may be modified by knowledge of influenza, attitude about vaccination and 
the nature of the practice setting. 
De.pendent Domain: Intent to immunize 6 to 23 month old infants for influenza 
Independent Domain: Level of physician training 
Specific Aims 
Specific Aim 1. To determine the relationship of physician training level on intent to 
vaccinate 6-23 month old infants for influenza 
Specific Aim 2. To determine if knowledge of influenza, the nature of the practice or 
attitudes toward vaccination affect this relationship 
Background and Significance 
Influenza represents one of the major epidemic and pandemic illnesses affecting 
humans and is a repetitive cause of human suffering, death and economic loss (Hilleman, 
2002). There are three strains of influenza, A, B, and C. Influenza C rarely causes disease 
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in humans. Influenza B is strictly a human virus that annually causes epidemics of 
respiratory infections, usually in the winter. Influenza A is the most important virus of the 
group, causing annual outbreaks and epidemic. This agent not only infects humans, but a 
variety of other vertebrates and it periodically cause pandemic disease with high 
morbidity and mortality (potter, 2001). 
All influenza viruses are negative-stranded RNA viruses whose genomes are multi-
segmented (Hillemann, 2002). The virus possesses a lipid envelop derived from the host 
cell, but is modified by insertion of viral proteins. There are two very important proteins 
in the envelope, hemagglutinin (H) and neuraminidases (N). The H protein acts as the 
major attachment protein that binds to sialic acid on the cells surface to initiate infection. 
Antibody to the H protein provides protection from infection. The neuraminidase has 
enzymatic activity that degrades sialic acids and is important for the virus to free itself 
from the cell following replication. It is also immunogenic and antibody to it provides 
some host protection. Both the H and N proteins are used to type and catalogue the 
influenza A virus strains. For example, the current influenza A viruses circulating in 
humans are H3N2 and HINt. There are currently 16 known H proteins and 9 N proteins. 
(Treanor et aI., 2005) 
The segmentation of the genome is an important feature of influenza viruses. The 
segmentation allows the virus to reassort its genetic material in nature if simultaneous 
infection with two viruses occur in the same host. This is though to be an important 
mechanism in adaptation to human infection (Hilleman, 2002). 
Migratory birds act as the major reservoir for influenza A and they are hosts for 
many different strains of influenza (palese, 2004). Periodically, one of these strains will 
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adapt to infection in humans. The appearance of a new strain of influenza in a population 
with no immunity results in a world wide outbreak, known as a pandemic, with over 80% 
of people affected in the frrst two years and results in large mortality. During the 
influenza pandemic of 1918, it is estimated that the 20-40 million people died worldwide. 
Pandemics occur in cycles approximately every 10 to 40 years. There were three 
pandemics in the 20th century, the last occurring in 1968 with the appearance of the Hong 
Kong influenza (H3N2) (Cox, 2000). 
Following a pandemic, the new strain of influenza becomes endemic, causing annual 
winter epidemic of respiratory infections. Influenza is an RNA virus and its RNA 
polymerase has no editing function to correct mistakes during RNA replication. As a 
result, the virus is constantly introducing small mutations which gradually change the H 
and N proteins. This process, known as antigenic drift, alters the immune profile of the 
virus. The result is that the virus becomes antigenically different from its ancestors and is 
able to cause infection in people who have previously been infected by its closely related, 
but different cousin. 
Influenza is primarily spread person to person by droplet infection (Murphy, 1996). 
People become infectious 1 to 2 days prior to clinical illness. The virus infects the 
respiratory mucosa of both the upper and lower respiratory tree (Hilleman, 2002).Virus 
replicates in and kills the ciliated mucosal cells. This denuding of the respiratory mucosa 
leads to decrease protection of the respiratory tract and susceptibility to secondary 
bacteria infections. In most infections, influenza viruses are restricted to the respiratory 
tract and do not infect other organs. This is due to the fact that the H molecule of the 
virus has to be acted upon by a host cell protease that is restricted to the respiratory cells. 
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This acts to confining the virus to the respiratory tract. However, there are a number of 
highly pathogenic influenza viruses whose H molecule has been modified so it can be 
acted on by proteases outside the respiratory tree and thus spread to other organs. The 
current Avian influenza (H5Nl) is such a virus. Although Avian influenza has not fully 
adapted to humans with person to person spread, individuals infected with Avian flu have 
virus in organs other than the respiratory tree (dejong, et al. 2005). 
How does a virus restricted to respiratory tree manage to cause so many systemic 
symptoms? It appears that the influenza virus infection induces a vigorous cytokine 
immune response that leads to the systemic symptoms of malaise, fever, myalgias. 
The incubation period of influenza is short, 1 to 4 days (average 2 days) (Cox, 1999), 
and the onset of illness is generally rapid. It is characterized by signs of respiratory tract 
damage, including cough rhinorrhea, otitis media and sinusitis. The systemic symptoms 
include fever, mylagias, malaise and anorxia. Illness generally lasts 3 to 7 days, although 
cough and malaise can persist of up to 2 weeks. Influenza can exacerbate underlying 
medical conditions such as asthma, cardiac or pulmonary disease. In addition, 
complications such as secondary pneumonia due to Staphylococcus aureus or 
Streptococcus pneumonia also occur. 
Because of the unique biology and epidemiology of influenza, epidemics occur 
annually in the winter and are associated with increases in morbidity, death and economic 
loss. It is estimated that 9% of the world popUlation are affected annually by influenza 
(Ghendon, 1992). 
The hemagglutinin and neuraminidase proteins of the influenza virus envelope, the 
antigens that lead to protective immunity, undergo gradual progressive changes due to 
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mutations of the viral genome. This results in a process known as antigenic drift (Potter, 
2001). As a result, the circulating virus each year differs from previous influenza strains. 
This problem is compounded by a gradual decline in virus-specific mucosal immunity. 
As a result, individuals gradually become susceptible to re-infection with the current 
circulating virus. This leads to annual outbreaks of infection which occur primarily in the 
winter in the northern hemisphere. 
Influenza is known to affect 10-20% of the US population each year resulting in 
200,000 hospitalizations and 36,000 deaths annually (Simonsen, 1999, Thompson et aI., 
2003). Associated direct and indirect costs are estimated at $37 billion a year (American 
Lung Association, 2004). While infections occur in all segments of the population, 
serious disease occurs in specific high-risk groups such as the elderly, people with 
chronic cardiopulmonary disease, pregnant females and infants. Influenza infections are 
frequent in children and infants. Moreover, infants and children playa significant role in 
driving epidemics by introducing infection into other segments of the popUlation 
(Principi and Esposito, 2004). In community studies, school-aged children have had the 
highest rates of influenza infection. Population-based surveillance studies have shown 
that infants and children have the highest annual attack rates, with rates of 40% in 
preschool and 30010 in school aged children (Fox et ai, 1982; Glezen and Couch, 1978; 
Glezen et ai, 1991; Longini et ai, 1982; Monto et ai, 1969; Wright et ai, 1977). Having 
an infant or child with influenza in the household is the most important detenninant of 
influenza in the family (Fox et ai, 1982; Foy et ai, 1976). In addition, a number of studies 
have shown that large scale vaccination of healthy children reduces the incidence of 
influenza infection in all age groups (2004; Glezen et ai, 1991). It is now recognized that 
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infection of infants is associated with significant disease. The risk of infection-associated 
hospitalization in healthy children <24 months has been shown to be equal or greater than 
that of other high risk groups. The risk of hospitalization for infants 0-2 years of age 
ranges from 144 to 1038 per 100,000 per year which is comparable to rates of patients 
~5 (Izurieta et ai, 2000; Neuzil et ai, 2000). 
Immunization has been shown to be effective in reducing morbidity and mortality 
due to influenza (Harper et ai, 2004; Munoz, 2003). However, this efficacy is influenced 
by many factors, including age, the inclusion of relevant antigens in the vaccine, and 
previous experience with vaccination or infection. It is known that response to vaccine 
initially increases with maturity, peaking in adolescence and then declining with age 
(Bridges et ai, 2003; Munoz, 2003). However, the response rates in children previously 
vaccinated or with prior infection are 85-90%. In contrast, previously unvaccinated 
children require two doses of vaccine to develop protective immunity (Jacobson, 2002, 
Ritzwoller, 2005). 
Neutralizing antibodies to the H and N proteins were shown more than three decades 
ago to be protective from infections and disease with influenza A virus (Murphy et a1. 
1972, Virelizier, 1975). Administration of these proteins remains the basis of 
immunization for influenza . 
There are currently two types of influenza vaccmes available. The trivalent, 
inactivated, split-product vaccine (TN) is an inactivated vaccine containing purified H 
and N proteins derived from the most recent circulating viruses influenza A, H3N2 and 
Hlnl, as well as Influenza B H and N. This vaccine is updated annually and is given 
parenterally by intramuscular injection. There is now trivalent live attenuated influenza 
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vaccine (LAN) that is administered intranasally. The H and proteins of the relevant 
strains of influenza A H3N2 and HINI and from influenza B have been inserted into a 
cold-adapted vaccine strain of virus. The LAN is indicated for healthy individuals ages 5 
to 49 years. Both vaccines are generally well tolerated with minimal side effects. The 
TN is associated with soreness and occasionally low grade fever as the most common 
side effects (Bernstein et ai, 1982; Hall et ai, 1977). A retrospective study of 251,000 
children 6 months to 17 years who received influenza immunization showed no increase 
in medical events related to vaccination (France et ai, 2004). Since the TN is inactivated, 
it is impossible to develop influenza infection as a result of immunization, a common 
misconception. 
Influenza vaccine has been shown to reduce both health care costs and productivity 
losses associated with influenza infections. A number of studies of influenza vaccination 
of persons 65 years and older has shown a cost savings and significant reduction in 
hospitalization and mortality (Mulloly et al. 1994; Arden et al. 1986; Riddiough, 1983). 
Studies of patients less than 65 years of age can reduce losses due to work 
absenteeism (Nichol et al. 1995; Campbell and Rumley, 1997; Memicheli et al. 2000). 
This included reductions in health care visits, lost work days, and antibiotic use for 
influenza associated illnesses. The cost-efficacy of immunization aged 50-64 has not 
been studies and there a very few studies examining the economics of immunizing 
children. Two studies using either the parenteral vaccine or the live attenuated vaccine 
both demonstrated that it is economically advantageous to immunize preschool children 
is. (Cohen and Nettle man, 2000; Luce et al., 2001). 
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Protective efficacy of vaccination in children against infection confirmed by positive 
cultures varies from 30 to 95% depending on the study variables (Gruber et ai, 1990; 
Doberman et ai, 2003; Hurwitz et ai, 2000). Immunization of school-aged children has 
been shown to diminish the incidence of disease in all age groups including the elderly 
(Monte et ai, 1969; Reichert et ai, 2001). Whether universal immunization of young 
children would result in a net cost or saving is still controversial and would depend on the 
infection attack rate, rates of health outcomes and the cost of immunizing (Principi and 
Esposito, 2004). Total cost of immunizing includes both direct and indirect costs. Direct 
costs include supplies, personnel and administrative expenses. Indirect costs include time 
lost by care givers and parents/guardians to have their children immunized. The overall 
results of a number of studies have indicated universal childhood vaccination is a low-
cost preventive intervention that provides health benefits during epidemic periods 
(Nichol, 2003). 
Because of the key role infants play the epidemiology of influenza and their 
susceptibility to disease, in 2003 the ACIP included the age group 6 to 23 months as a 
target group for annual vaccination using the IFV (Bridges et ai, 2003). In 2006, while 
this study was in progress, the ACIP extended its recommendation to include 
immunization of children 6 months to 5 years (MMWR 2006 Jul 28;55(RR1O):1-42). It 
has previously been shown that infants who have not previously been vaccinated require 
two doses of vaccine a month apart to develop protective immunity (Jacobson, 2002, 
Ritzwoller, 2005). The need for two doses of vaccine increases the economic and 
logistical complications of this vaccine recommendation. 
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Studies in the past have show that there are many barriers to vaccination in general 
and to influenza vaccination in particular. (Hermiston and Rosenthal, 2005; Kimmel et ai, 
2003; Mieczkowski and Wilson, 2002). These include factors related to the physician, 
patient/parent related issues, economic factors and logistical issues. International 
literature has shown that knowledge or beliefs of health care providers about vaccination, 
especially contraindications, playa critical role in vaccine uptake (peckham et ai, 1986; 
Taylor et ai, 1997; Zimmennan et ai, 1997). 
In a study by Martinello et al., physicians and nurses were surveyed to determine 
whether commonly held misconceptions regarding influenza vaccine were associated 
with vaccine acceptance (Martinello et ai, 2003). Two hundred twelve health care 
workers completed a five question survey to assess general knowledge of influenza. The 
five basic questions were answered correctly by 166 (78%) of the 212 subjects. Health 
care workers with a correct understanding of influenza vaccine were significantly more 
likely to have accepted vaccination than those with misconceptions (84% vs. 64%, p < 
0.001). 
A study of the influence of attitudes toward influenza immunization found that 
acceptance of immunization by physicians (N = 46) was correlated with a desire for self-
protection (87%) patient protection (87%) and setting a good example (46%) (Heininger 
et al. 2003). Unvaccinated physicians (N = 25) indicated doubts about efficacy (56%), 
doubts about necessity (32%) and fear of side effects (24%). 
Two studies have examined flu vaccination in the 6-23 month old population. Using 
a pre-post intervention strategy, Zimmerman et al. examined the feasibility of improving 
vaccine rates (Zimmerman et al., 2004). Interventions included HeW education, 
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increased access to vaccination through work, after work clinics and vaccination 
reminders. Interventions were associated with an increase in first dose vaccination rate 
(6.9% to 38.5%, p < 0.01) and second dose rates of 1.9% to 13.2%. The results suggest 
that such interventions may improve vaccine uptake, but point out the difficulty of 
administering the second dose. They attributed this to the difficulties inherent in 
introduction of a new vaccine requiring two doses, which include tracking the patients, 
scheduling return visits and the complexity of the current pediatric vaccine schedule. 
In a study by Humiston et al., pediatricians and family physicians were mailed a self 
administered survey focused on their attitudes regarding feasibility of universal 
vaccination of children (Humiston et ai, 2004). Four hundred fifty-eight eligible 
physicians completed the survey (72% for pediatricians and 52% for family 
practitioners). When asked about vaccination of 12-35 month old children using 
parenteral or intranasal vaccine, the majority (80% of pediatricians and 69% of family 
practitioners) felt vaccination would be feasible and would reduce illness visits (67% of 
pediatricians and 57% of family practitioners). However, when children 6-23 months 
were posed as the target population and only parenteral vaccine was included, fewer 
physicians (50% of pediatricians and 40% of family practitioners) felt vaccination would 
be feasible. The issues cited were additional cost, vaccine safety and inability to track 
eligible patients. 
Patient factors also provide barriers to influenza immunization. A recent study 
examined parental perspectives on influenza immunization of children 6 to 23 months of 
age (Norwalk et al. 2005). A low literacy level, 19 question survey was sent to parents of 
436 children aged 6 to 23 months with a response rate of 43.6%. The most important 
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factors leading to immunization were physician recommendation (odds ratio = 5.5%; 
95% confidence interval = 2.4 - 12.3%, P < 0.001) and belief that the immunization 
would be effective (odds ratio = 3.5%; 95% confidence interval = 1.3 - 8.9%, P < 0.001). 
Barriers to immunization were similar to other studies (Grant, et al., 2003, Fitch, et al., 
2004). A significantly higher number of parents of unvaccinated children held the belief 
that the immunization would cause influenza (X2, p = 0.008). 
In addition to physician and patient barriers to influenza immunization, there are a 
nwnber of economic and logistical obstacles to immunization. Direct expenses include 
cost of vaccine, personnel and administrative costs. Indirect expenses include lost work 
and time travel. Logistical barriers include the requirement that primary vaccination 
needs two immunizations one month apart to establish immunity (Jacobson, 2002, 
Ritzwoller, 2005). This requires an additional appointment with travel time and lost 
work. In addition, 16 immunizations are currently required in the first two years of life 
and the addition of two additional immunizations would increase the complexity of this 
regimen (MacIntosh, 2007). 
Another logistical barrier is the ability to identify, track and recover candidates for 
vaccination. One study found that to identify children with high-risk medical conditions 
(e.g. asthma) who need influenza vaccination, 35% of the responders used computer files, 
24% used manual medical record review and 31 % relied on hand written lists (Humiston, 
2004). 
Thus, studies related to vaccination in general and to influenza specifically indicate 
that there are a number of barriers to vaccine utilization. Clearly, health care workers play 
an important role in vaccine usage. This research examined whether a physician'S level of 
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medical training affects the intent to vaccinate for influenza. It may be that this is not a 
direct relationship but rather a marker of other factors that influence vaccine usage. 
Research Design 
Introduction and Overview 
Health care workers have been identified as playing a pivotal role in the utilization of 
influenza vaccine (Zimmerman et ai, 1997). Because of this role, it is important to 
understand what factors might affect influenza vaccine utilization. This proposal 
examined the relationship of the level of physician training on their intent to vaccinate 6-
23 month old infants for influenza. It also examined whether this relationship is modified 
by physician knowledge of influenza, nature of clinical practice or physician attitudes 
toward immunization. The research model is depicted below. 
Research Model 
Description/DerlDition of Domains 
Intent to 
Immunize 
6-23 month 
For Influenza 
The dependent domain examined was the intent to immunize 6 to 23 month old 
infants for influenza. This was measured by utilizing the responses of the sample 
13 
physicians regarding their intent to provide immunization to that specific age group 
according to the ACIP guidelines. 
The level of medical training describes previous medical education including 
post-doctoral training to first certification, additional specialty training and 
continuing medical education activities. This was assessed by the responses of those 
surveyed. 
Knowledge of influenza describes the level of understanding of the biology, 
epidemiology, clinical character, treatment and prevention of influenza infection 
with emphasis on the impact of infection in the 6-23 month old popUlation. This 
was assessed by the respondents' answers to questions regarding influenza partially 
adopted from Martinello et al.(Martinello et ai, 2003). 
Attitudes toward immunization describe basic beliefs regarding the role of 
immunization in health care including efficacy, indications and contraindications 
and the inclination to use vaccines. This was assessed by responses in the survey 
regarding vaccination. 
Nature of medical practice refers to the type of medical practice including 
location (rural, suburban, urban), size and structure (solo, partner, group, HMO, 
academic), types of patients served, financial strata of patients, and medical record 
keeping. 
The relationship between level of physician training (independent domain) both 
directly and indirectly and the intent to vaccinate (dependent domain) was the primary 
focus of the study. Knowledge of influenza, attitudes toward immunization and the nature 
of practice were also examined as they might moderate/influence this relationship. 
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Hypotheses 
The main hypothesis of this proposal was that the level of training directly affects a 
physician's intent to vaccinate 6-23 month old infants for influenza. This relationship 
may be modified by knowledge of influenza, attitude toward immunization and the nature 
of their medical practice. 
Specific Aims 
1. To determine the relationship of physician training level on intent to vaccinate 6-
23 month old infants for influenza 
2. To determine if knowledge of influenza, the nature of their practice or attitudes 
toward vaccination affect this relationship 
Description of Study Population 
The target population for this proposal was a cross sectional sample of pediatricians 
and family practice physicians practicing in the state of Connecticut. A list of all licensed 
pediatricians (1118) and family practitioners (608) was compiled from computerized 
directory of physicians of the Connecticut State Department of Public Health medical 
licensing unit. 
Sampling Approach 
A random sample of 200 pediatricians and 200 family practitioners was chosen from 
this list using systematic random sampling. The first on the list was selected using a 
random number method. Subsequent subjects were then selected using every fourth 
physician in the list until 200 of each group were identified. 
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Data Collection Methods 
Self-administered Survey 
Quantitative data was collected by a self-administered survey mailed with the help of 
the Connecticut Department of Public Health's Immunization Program to a random 
cross-sectional sample of 200 pediatricians and 200 family practice physicians in the 
State of Connecticut. The survey included a cover letter explaining the purpose of the 
study, instructions for the survey and an addressed stamped return envelope. The first 
mailing occurred in May, 2006. A second follow-up mailing was done to try to increase 
the response rate. This occurred in September of 2006. 
The survey was developed de novo during a course on Public Health Research 
Methods. There were six sections. The first section was designed to assess the 
demographic characteristics of the responders. The next two sections were meant to 
assess the type of clinical practice. The fourth section was designed to assess the 
respondent's knowledge of influenza. It was derived from the survey of Martinello et a1. 
(Martinello et al. 2003). The fifth section was to assess the attitudes toward influenza 
immunization. The final section was to assess the intent to immunize for influenza. Once 
the survey was assembled, it was sent to three pediatricians for field testing and 
refinement. A sample of the survey instrument is attached (Appendix I). 
Quantitative Data Analysis 
Statistical Package for the Social Sciences (SPSS, version 12) was used to analyze 
quantitative data. Initially the data was cleaned and descriptive statistics run for all 
variables. The nonnality of the distribution of the responses to all variables was checked 
using SPSS frequency distribution, mean, mode, median, standard deviation, range, 
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maximum and minimum for each category. Associations were performed by cross-tab 
using SPSS and by calculating Odds Ratios (OR), 95% confidence intervals of OR and 
using X2 to detennine p values. Fischer's exact test was used for cells with values of :55. 
Results 
Of 400 physicians sent surveys, 195 (48.8%) were returned for evaluation (Table 1). 
A total of 81 of 200 (40.5%) surveys were returned by family practice physicians while 
114 of 200 (57.0%) were returned by pediatric physicians. The data was analyzed 
separately for family practice physicians and pediatric physicians and then combined and 
reanalyzed. Table 1 summarizes the demographic characteristics of the two study groups. 
Family Practice 
Of the 81 family practice surveys returned, 29 (35.8%) indicated that they did not 
offer vaccination, while 52 (64.2%) did and were included in the study (Table 1). The 
reasons for not offering vaccination were not systematically evaluated, but many 
respondents indicated they were retired or worked in areas that did not include 
vaccination such as research, administration or academic positions. Analysis of the 
demographics of the remaining respondents revealed that 32 (64.2%) were male and 20 
(35.8%) were female. Most of the family practice physicians were white, non-Hispanic (n 
= 45, 86.5%). The mean age was 48.0 ± 8.6 with a range of 30 to 72 years. The mean 
year of graduation was 1984 ± 8.7 with a range from 1954-2002. The average level of 
post doctoral training was 3.2 ±.88 years. Nearly 100% of those responding reported 
participating in some form of category 1 continuing medical education (CME) with the 
average hours of54.7 ± 21.5 (range 20 to 150) 
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Pediatrics 
Of the 114 surveys returned, 29 (25.4%) indicated that they did not offer vaccination 
while 85 (74.6%) did and were included in the study (Table 1). The demographic 
characteristics indicated that 46 (54.1%) were male and 39 (45.9%) were female. Most of 
the pediatric physicians were white, non-Hispanic (73, 85.9%). The mean age was 
48.3±8.6 with a range of 30 to 75 years. The mean year of graduation was 1983 ± 11.7 
with a range from 1959-2001. The average level of post doctoral training was 3.6 ± 1.0 
years. Nearly 100% of those responding participated in some form of category 1 CME 
with the average hours of 50.7 ± 24.5 (range 20-150). 
Combined Practice 
The characteristics of the combined practices are shown in Table 1. One hundred 
ninety five of the 400 (48.8%) surveys were returned. Fifty-six (28.7%) did not offer 
vaccination while 137 (70.3%) indicated that they did. Thus, 34.2% of the original 
mailings could be included in the study. 
Characteristics of the Clinical Practices 
The types of clinical practices for the pediatricians and family practitioners were 
compared (Table 2). There were more solo and one partner practices for family 
practitioners (34.6% vs. 13.1%) and more group practices for pediatricians (64.3% vs. 
48.1 %). However, overall the differences in the practices were not statistically different. 
In addition, rural practices were somewhat more common for family practitioners (19.6% 
vs. 4.7%) and urban more common for pediatrics (24.7% vs. 11.8%). There were similar 
numbers of suburban practices in both areas. These differences were statistically 
significant (X2 = 13.7, df= 2, p = 0.001). 
18 
The majority of patients in both family practitioners and pediatricians were white, 
non-Hispanic, but pediatric practices included a larger percentage of Hispanic patients. 
While this was an interesting, trend it was not of statistical significance. However, 
pediatricians estimated that their practices included a higher percentage of minority 
patients than family practitioners (43.4% vs. 26.9%). This difference in the two practices 
was statistically significant t/! = 5.7, df= 1, P = 0.017). 
The clinical practices for record keeping, vaccine tracking and vaccine 
administration were also compared. Electronic medical records were infrequent in both 
pediatric practices (n = 14, 16.5%) and family practices (n = 13, 25.0%) (Table 3). 
Similarly, neither vaccine reminders nor standing orders were very common in either 
practice type. The majority of both practice types held vaccine clinics (pediatrics 55.3% 
and family practice 63.5%). None of these characteristics were statistically different. In 
contrast, a larger percentage of pediatric practices (60.0% vs. 28.8%) were utilizing 
vaccine tracking systems. This difference was statistically significant (X2 = 14.1, df= 1, P 
= 0.0002). 
Since the demographics of the pediatric physician and family practice physicians 
were so similar, in general aggregate data will be presented. When differences were 
noted, they will be presented separately. 
Knowledge of Influenza 
A series of seven questions were asked to assess the physician's knowledge of 
influenza (Table 4 and 5). Five of these were modeled after Martinello et ale with some 
modifications (Martinello et al. 2003). Both the family practice physicians and the 
pediatric physicians demonstrated a very high level of knowledge of influenza. There was 
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only one area in which there was significant variation. When asked about influenza in 
children compared to adults 53.8% of family practice physicians and 57.6% of pediatric 
physicians indicated influenza was more common in children while 46.1 % of family 
practice physicians and 36.4% of pediatric physicians said no or did not know. This 
difference in the two groups was not significant (X2 = 3.3, df = 1, p = 0.067). However, 
when overall awareness by combined groups of the increased level of influenza infection 
in children versus adults was examined by age, there was as significant difference. The 
age of the physicians was inversely correlated with awareness, with the younger 
physicians being less aware that influenza is more common in children than adults. 
(45.0% vs. 31.7% vs. 23.3%, .J! for trend = 11.0, df= 2, P = .004). For this analysis, the 
responding physicians were grouped into three age brackets, each age group representing 
roughly a third of the physicians. For the combined analysis 31.4% were =5 41, 32.4% 
were 42 to 52 and 35.8% were 2: 53 years. When further analyzed, this age relationship 
and awareness was only significant for the pediatricians (52.9% vs. 26.5% vs. 20.6%, X2 
for trend= 9.19, df = 2, P = .010), not the family practitioners (45.8% vs. 25.0% vs. 
29.2%, X2 for trend = 3.0, df = 2, p = .285) (Table 5). Identical results were obtained in 
analysis of groups using year of graduation and years in practice, but these two variables 
were likely surrogate markers for age. 
Attitudes Towards Influenza Vaccination 
A series of six questions were asked to assess physician attitudes regarding influenza 
vaccination (Table 6). Again there was little variability with a high rate of positive 
attitudes regarding vaccination. The vast majority (-95%) felt influenza vaccination was 
an effective health care tool, was generally safe and that serious side effects were 
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uncommon. Most practitioners felt vaccination should be a part of practice. Virtually all 
reported receiving vaccine (94.9%) the year of the survey, the primary reasons being self 
protection (94.2%) and protection of their patients (90.5%). Only 45.3 % indicated they 
accepted immunization to set a good example. There were too few physicians who were 
not immunized to evaluate their reasons for declining. Overall, 95.6 % of clinical 
practices also offered vaccination for office staff. 
Intent to Vaccinate for Influenza 
A series of six questions were used to assess physician intent to vaccinate (Table 7-
10). Analysis revealed that there was very little variation between pediatric and family 
practice physicians in their response to these questions. All indicated that they 
recommended and offered annual influenza vaccination to at least some of their patients 
(Table 7). When patients were stratified by age, almost all physicians did not vaccinate 
prior to six months and most vaccinated children in the 6 to 23 month age group (table 7). 
A very high percentage of both practices reported intent to vaccinate in the 6 to 23 month 
old age group. Interestingly, the percentage of physicians who reported offering influenza 
immunization to children in the subsequent age groups declined to 45-55%. This was 
examined for both pediatricians and family practitioners (Table 7). 
The current recommendation for primary immunization is two doses one month 
apart. The responses to how many doses of influenza vaccine were being recommended 
for primary immunization was assessed (Tables 8 and 9). It should be noted that for this 
question, there was a very high no response rate when asked how many doses of vaccine 
would be used for children < 6 months of age. This was true of both the pediatric surveys 
(n = 14, 12.3%) and the family practice surveys (n = 18, 22.2%). There was also a very 
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high no response rate by family practitioners for the remaining age groups; 13.5% for 6-
23 months, 25% for 2 to 8 years and21.2% for children > 8 years. The responses 
indicated that the majority of physicians did not vaccinate prior two 6 months, although 
22.1% responded that they did. The majority (87.0010) recognized that two doses were 
needed for primary influenza immunization. 
The data available for this evaluation of the final two questions assessed whether 
practitioners were aware of the ACIP recommendations for immunization of 6 to 23 
month old infants and the estimate of those who actually received the two doses (Table 
10). The data set is smaller due the fact that significant number of defective surveys 
lacking these two questions were sent out in the first mailing. This resulted in the loss of 
52 responses, leaving 95 for evaluation. Responses were available from 58 (63%) 
pediatric and 33 (36%) family practice responses, the same proportions for each group as 
the original data set. All pediatricians (55, 100%) reported being aware of the ACIP 
recommendation to vaccinate the 6 to 23 month old age group, using two doses of 
vaccine, but fewer family practitioners (33, 89.2%) were aware (Table 10). This 
difference is statistically significant (Fischer's exact test, p = 0.021). Despite the 
awareness of these recommendations, respondents estimated that at least 35.1% of their 
6-23 month old patients received only one of the two recommended immunizations 
(Table 10). 
Predictors of Not Offering Influenza Vaccine to 6-23 Month Old Children 
The major focus of this survey was to determine factors related to the intent to 
vaccinate 6-23 month old children for influenza. A number of variables that could be 
predictors of not offering influenza vaccine to 6-23 month old children were examined 
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(Table 11). There was a trend for family practitioners to be less likely to offer vaccination 
than pediatricians, but this did not reach statistical significance (Odds Ratio 3.14, p = 
0.066). Practices that were not located in urban areas were significantly less likely to 
offer influenza vaccination than practices in urban settings (Odds Ratio 6.70, p = 0.041). 
Having a vaccine tracking system, which was more common for pediatricians, also 
demonstrated a trend of being associated with offering influenza vaccination to 6-23 
month old children, but this did not reach statistical significance (Odds Ratio 9.60, p = 
0.078). There was an inverse relationship with practices using vaccine reminders and not 
offering vaccination (p = 0.030). In contrast, practices not providing vaccine clinics were 
significantly less likely to offer influenza vaccination to the target population (Odds Ratio 
3.54, p = 0.001). Also, considering influenza immunization as an important part of 
medical practice was also significantly associated with offering vaccination to 6 to 23 
month old infants (Odds Ratio 14.00, p = 0.001). Finally, having a practitioner accept an 
influenza immunization in the last year was also associated with offering immunization to 
the target population (Odds Ratio 6.14, p = 0.048). 
Immunization of<50% of6 to 23 Month Old Children With Two Doses of Vaccine 
A variety of variables that might predict whether the estimate that <50% of 6 to 23 
month old children in practices who received an initial dose of influenza vaccine would 
receive a second dose were analyzed (Table 12). The only variable showing a significant 
association with not offering influenza vaccination was the hours in practice per week. 
Patients were less likely to receive a second dose of vaccine if their practitioners worked 
<40 hours per week (Odds Ratio 6.14, 0.91:::;OR<5.70, P value = 0.027). 
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Conclusions and Discussion 
The main hypothesis of this study was that the level of a physician's medical training 
directly affects their intent to vaccinate 6-23 month old infants for influenza and that this 
relationship could be modified by knowledge of influenza, attitude regarding vaccination 
and the nature of clinical practice. This hypothesis was predicated on the expectation that 
there would be variation in their knowledge, level of training and attitudes as had been 
demonstrated in previous studies. Ultimately, this hypothesis could not be directly tested 
due to the lack of variation in the study groups. The results demonstrate that there is very 
little variation in these domains for either the pediatricians or family practice physicians. 
Nevertheless, some very interesting information is forthcoming from these results. 
The demographic characteristics of the family practice and pediatric physician 
responders revealed striking homogeneity in their ethnicity, gender, age distribution, 
postdoctoral training and continuing medical education activities. There was some slight 
variation in their clinical practices with more pediatricians in group practice and more 
family practitioners in solo or one partner practices, although this was not statistically 
significant. Most of the practices were suburban for both groups. The locations of the 
practices did reach statistical significance with more family practices in rural areas and 
more pediatric practices in urban areas. This might be ascribed to the nature of family 
practice which involves a larger spectrum of age groups. Such practices might be needed 
more in rural areas than pediatrics. The ethnic mix of the patient populations was not 
significantly different. 
The methods of patient tracking and contact were examined. Most practices have not 
adopted electronic medical record keeping, but pediatricians more frequently relied on 
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vaccine tracking systems, a difference that was statistically significant. This is likely due 
to the standard of practice in pediatric practice to follow a highly defined vaccination 
schedule. The establishment of an electronic medical record or vaccine tracking system is 
highly likely to improve vaccine administration by identifying those in need of 
vaccination and issuing reminders to physicians or ancillary staff. Implementing these 
practices would be an important step in removing barriers to vaccination. This would help 
physicians to identify and track individuals needing influenza vaccination. Prior studies 
have shown the importance of physician recommendations on influenza immunization 
acceptance (Heininger et al. 2003). 
The physicians surveyed demonstrated a high level of knowledge of influenza, and 
were actively involved in continuing medical education at all age levels. These high 
levels of CME activity are likely due to long standing requirements of many health care 
insurers in the state of Connecticut for physicians to participate in ongoing CME to be a 
member of their provider network. In addition, in October, 2005, just prior to the conduct 
of this study, the State of Connecticut enacted legislation defining the requirements for 
CME. This mandated at least 50 hours of category I CME in 24 months for all licensed 
physicians. Virtually all of the physicians reported compliance with this requirement. 
The only significant deficiency in knowledge of influenza that was identified was an 
age related awareness that influenza infections are more common in children than adults. 
Overall 40.2% of physicians surveyed were unaware of the high level of influenza 
infection in children. This was inversely correlated with the age of the physicians, years 
of practice and year of graduation, with a lower percentage of younger physicians being 
aware. Whether age, year of graduation or years of practice are independently related or 
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are a surrogate of age alone was not determined. When further analyzed, this was only 
significant for the pediatricians. This relationship of knowledge of influenza and 
increasing age has been previously reported (Rickert, et a1. 2006). It is not clear why 
younger pediatricians would be unaware that influenza is more common in children than 
adults. It could possibly be related to a pediatrician'S lack of familiarity with adult 
patients proximate to the completion of their training. Nevertheless, this lack of 
awareness could influence immunization practices in children in the 2 to 5 year age. This 
is relevant because in 2006 the ACIP changed its recommendation to include 
immunization of children 6 months to 5 years. In examining the rates of immunization for 
the 2 to 5 year age group (Table 7) influenza immunization was only occurring for -50% 
of children in this age range the time during the survey period. 
The high level of knowledge of influenza found in this survey was somewhat 
surprising based on the result of other research which found a significant variation of 
knowledge and attitudes about influenza vaccination. Martinello et al. found significant 
variation in basic knowledge of influenza among 212 health care workers (Martinello, 
2003). Moreover, the knowledge of influenza was significantly associated with whether 
they accepted influenza vaccination for themselves, a finding that has been reported in 
other studies (Heininger, 2003). This may be related to the likelihood that physicians are 
more knowledgeable regarding influenza than other health care workers as was 
previously seen (Martinello, 2003). 
Regarding physician attitudes toward influenza vaccination, most felt that influenza 
vaccination was effective, safe and without common major side effects and was an 
important part of medical practice. Virtually all had reported receiving vaccine (94.9%) 
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the year of the survey, the primary reasons being self protection (94.2%) and protection 
of their patients (90.5%). Only 45.3 % indicated they accepted immunization to set a 
good example. There were too few physicians who were not immunized to evaluate their 
reasons for declining. These finding were somewhat different from those of Heininger et 
al. who found a higher rate of physicians that were not immunized (Heininger et al. 
2003). They also found a greater variation in the knowledge of influenza which was 
correlated with non-acceptance of immunization. In that study, those accepting 
immunization, 87% reported self-protection, 87% protection of their patients and 46% 
setting a good example, very similar to our findings. Most physicians in this survey not 
only accepted influenza immunization themselves but also offered immunization to their 
office staff (95.6%). 
The respondents also indicated a high rate of intent to vaccinate for influenza (Table 
7). All of the clinical practices offered and recommended influenza vaccination for at 
least some of their patients. Examining vaccination for the various patient age groups also 
revealed some interesting findings. The majority of pediatricians and family practitioners 
reported following the ACIP guidelines for vaccinating the < 6 month old and the 6 
month to 23 month old children. However, in all other age groups influenza vaccination 
dropped to around 50%. This survey antedated the recent change recommended by the 
ACIP regarding 6 month to 5 year old children. This could also have been influenced by 
the high rate of no response for this question. However, it implies that the majority of 
practitioners do not appear to appreciate the role of influenza infection in children as a 
major driving force in annual epidemics. 
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possible that this is based on some configuration of practices in non-urban areas. The 
basis of this association also merits further study. 
Practices using vaccine tracking systems were significantly more likely to offer 
vaccination to 6to 23 month old children, Vaccine tracking systems were significantly 
more common in pediatric practices compared to family practices. Development of 
vaccine tracking systems in other practices might significantly improve administration of 
influenza immunization. 
Finally, the acceptance of an influenza immunization by a physician was a strong 
predictor of offering immunization. This is likely represents an acceptance that influenza 
immunization is an important part of medical practice as the majority responded (Table 
6). 
The question that influenza was more common in children than adults identified a 
significant deficiency in the knowledge of in influenza. Further analysis indicated this 
was significant only for young pediatricians. However, when observation was examined 
for combined practices (Table 11) as well as pediatric practices (Data not shown) as a 
predictor of not offering influenza vaccine to the target population, it was found not to be 
a significant predictor. 
There were a number of associations in these analyses where tends were seen that 
approached, but did not reach statistical significance. While it may be true that there was 
no significant difference, it is also possible that this study was underpowered to detect a 
true difference. Given these trends, it would be an interesting area to further study with a 
larger sample. Power calculation prior to such a study would also be important. 
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There was a reported high degree of familiarity with the existing ACIP guidelines 
recommending vaccination of children 6 months to 23 months and most were aware of 
the need for two doses of vaccine for the primary series (Tables 8-10). Despite this 
awareness, it was estimated that only 35.1 % of patients received both immunizations 
needed for primary immunization. This important as this study focused on intent to treat 
which is very different from actual administration of vaccine. This disparity would 
suggest that, despite a reasonable fund of knowledge and appropriate intentions, fewer 
individuals actually end up receiving the recommended regimen. It is also important to 
note that these are estimates rather than documented rates. Thus, because of recall bias 
they may over-estimate the true vaccination rates. The reason for this difference in 
intention and actual vaccination was not delineated, but may be related to the logistics of 
administering two shots separated by a month. The current regimen for immunization in 
the first 6 years of life currently involves 10 vaccines in a complex pattern of 
administration (ACIP, http://www .cdc.gov/nip/acip, accessed 4/27/07). Administering 
two doses of influenza vaccine 1 month apart may impose obstacles such as patient 
tracking and convincing parents to return for a second visit. This would be an area for 
future study. 
The focus of this study was to investigate variables that might influence a 
physician'S intent to immunize 6 to 23 month old children. A number of variables were 
examined to determine if there was a significant association that would lessen the 
likelihood of immunization (Table 11 and 12). 
Non-urban practices were significantly less likely to offer influenza immunization to 
the target population. There is no clear explanation for this observation, though it is 
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As pointed out earlier, the survey responders reported a high degree of familiarity 
with the existing ACIP guidelines recommending vaccination of children 6 months to 23 
months and most were aware of the need for two doses of vaccine for the primary series 
(Table 10). Despite this awareness, 35.1 % of patients were estimated to have received 
only one of the recommended two immunizations needed for primary immunization. A 
number of variables were examined as potential predictors for estimating that <50% of 6 
to 23 month old children in practice who received an initial dose of vaccine also received 
a second dose of vaccine (Table 12). Of the variables examined, only working <40 hours 
a week was significantly associated with not providing a second dose of vaccine. There 
are a number of possible explanations for this association. It is possible that working part 
time increases the logistical barriers to second vaccination, either at the practitioner level, 
in the clinical environment using part time physicians or at the patient level. Physicians 
not working full time might not be as compelled to provide the second dose or have an 
appropriate work schedule to optimize immunization in the one month follow up 
window. They also might not be as effective at tracking patients needing second 
immunization. Clinical environments using part time physician may not be configured to 
track patients or provide follow up appointments. Patients may not be as comfortable 
with the recommendations of a part time physician, especially if they are seeing multiple 
physicians. Finally, this may be an example of Type I error in which a difference was 
seen when it was due to chance alone. 
Limitations 
There are some important limitations to this present study. Foremost was the lack of 
variation which precluded the ability to test the original hypothesis. This lack of 
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variability was due to the high level of knowledge of influenza and positive attitudes that 
vaccination is an effective tool in clinical practice, suggesting good clinical care and the 
impact of mandated CME. 
As with any self-administered mail survey, a major limitation is the number of 
surveys returned by the respondents. A poor response may strongly bias the interpretation 
of the results. While 48.8% of those surveyed responded and 34.1 % could be evaluated, 
the characteristics of the non-responders remain problematic. The lack of response may 
be an indictor of a lack of compliance with the recommendations in these practices. 
Alternatively, there could be reluctance to respond because they would admit not being 
aware or following the recommendations. To provide this missing data would require a 
direct survey a sample of the non-responders to detennine the reasons they did not 
respond and to assess the nature of their practice. 
Even with a random sample, there is always concern that the sample may not be 
representative of the population and that it may not be possible to generalize the results of 
the survey. One indication of a lack of bias in this survey was that the demographic 
characteristics of the physicians responding to this survey were very similar, although 
there was significant spread in age and years in practice. 
Other concerns include the fact that this survey instruments had limited field testing 
prior to its use. However, the response rate suggests it was relatively easy to taking and 
did not have ambiguous questions. 
Another potential pit-fall lies In self-reporting which relies on estimates of 
physicians, rather on actual events. Because of recall bias, this may exaggerate or 
inaccurately reflect the true state of affairs. For example, 61.2% of responders report that 
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>50 of their patients received the second dose of the primary series. However, this 
estimate may be exaggerated by an over-estimation of the actual rate. While this may 
reflect what is truly occurring, there no way to validate its accuracy short of a direct 
survey of medical records. 
The final limitation was missing data. This is illustrated by the loss of data for the 
last two questions due to defective survey instruments in the first mailing. This reduced 
the number of surveys that could be evaluated and thus reduced to power of those 
questions to detect differences. Such a decline in power may have obscured differences 
that truly existed in the assessment of whether practitioners were aware of the ACIP 
recommendations and the estimate of those actually receiving two doses of influenza 
vaccine. It would also reduce the chance to detect differences in influenza immunization 
of>50% of6 to 23 month old children. 
In some surveys, answers were simply not provided. This was generally under 5%. 
The one question where the rate of no response was very high involved the number of 
doses of vaccine to be used for each age group. It is possible that the question was 
confusing or that individuals did not know and thus did not respond. This would also 
reduce the power to detect differences. 
Translation of research into policy and intervention 
This research demonstrated that, at the time of the survey, physicians in the state of 
Connecticut understood the importance of influenza vaccination in general and were 
aware of the ACIP guidelines for 6-23 month old infants. Since the guidelines have been 
revised, it is important to educate the physicians about the new guidelines. It is also 
important to ensure that physicians are aware of the role that children play in the 
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epidemiology of annual influenza epidemics. Educational programs have been shown to 
improve compliance in vaccine recommendations in other situations. 
Another potential area of improvement would be the use of electronic medical 
records, vaccine tracking methods or development of reminders which could greatly 
impact vaccine administration. Previous studies have demonstrated the recommendation 
of a physician is an important factor in increasing immunization acceptance. Electronic 
medical records and vaccine tracking method can be configured to assist physicians and 
other health care professionals in identifying patients in need of vaccination. The 
recognition that these methods mayor may not improve vaccine coverage would provide 
an important area of clinical research. 
The use of large vaccine clinics was shown to increase the number of children 
receiving two doses of influenza vaccination. Practices should be encouraged to employ 
large scale vaccination clinics to reduce the number of infants not receiving the second 
dose of vaccine. 
Areas of potential future research would include characterizing the physicians that 
did not respond to the survey, to detennine why family physicians were less likely to 
provide influenza immunization than pediatricians, how the location of practice 
influences vaccination and why working <40 hours a week alters vaccine practice. 
Finally, it will be important to address some of the logistical and economic problems 
the primary influenza vaccination poses to improve the rates of children receiving both 
dose of vaccine. Patient acceptance and the belief that immunization is beneficial have 
been shown to increase vaccination rates. Patient education could play an important role 
in dispelling misconception related to immunization. 
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Table 1: Demographic Characteristics of Pediatric and Family Practitioners Respondents 
to the .... ""'"." 
Surveys 
Returned 
Provide 
Immunization 
Continuing 
Education 
Yes 
Yes 
HourslYear 
Mean + S.D. 
HourslYear 
Subscription 
to Medical 
Journals 
CMEOn-
line 
114 (57.0%) 
85 (74.6%) 
3.6±1.0 
82 (96.5%) 
50.0+24.0 
20-150 
81 (95.3%) 
38 (44.7%) 
--~ 
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81 (40.5%) 195 (48.8%) 
52 (64.2%) 
98.1% 133 (97.1 %) 
54.7+21.5 51.9+26.9 
20-150 20-150 
49 (94.2%) 130 (94.9%) 
23 (44.2%) 61 (44.5%) 
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Table 4: Assessment of the knowledge of influenza by the Pediatricians and Family 
Practitioners responding to the survey expressed as number and percent (%) of 
responses. 
Combined Practices 
Yes No DK NR 
1. Can the parenteral influenza 
vaccine cause influenza 
infection? ~~~m~!J 
Very 120 
Somewhat 17 
Minimally 
I 
*Differences statistically significant when cross tabbed with age (X2 = 11.0, df = 2, P = .004) 
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Table 6: Attitudes Toward Influenza Vaccination [n, (%)]. 
------- -~-----
Disagree 
-~-- ----
I 
1. Do you think 
immunization for Influenza 0 
is an effective health care (0.0%) 
tool 
Protect myself 129 
Protect my patients 
Set a good example 
7. Do you offer 
immunization for Influenza 
to of:ficesUUff? 
131 
(95.60/0) 
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Combined Practices 
2 
0 
(0.0%) 
2 
(1.5%) 
3 4 
8 31 
(5.8%) (22.50/0) 
Agree 
5 
98 
(71.0%) 
Table 7: Intent to Vaccinate [n, (%)]. 
Pediatrics 
Yes No I NR 
Do you offer annual 
Influenza vaccination to at 
least some of 
For which of the following 
age groups do you offer 
influenza vaccine to all in 
that age group? (Circle all 
that apply)[%] 
<6 months 
6-23 months . 
2-5 years 
6-10 years 
11-15 years 
>15 years 
Yes 
3.5 
92.9 
48.2 
41.2 
42.4 
41.2 
I No NR 
95.3 22.2 
4.7 1.2 
i 48.2 1.2 
-~ --
56.5 1.2 
55.3 1.2 
I 56.5 1.2 
I I 
I I 
i 
! 
40 
Combined Practices 
NR Yes I No J NR 
Yes i No NR I Yes I No NR I 
9.6 I 86.5 3.8 I 5.8 92.0 2.2 
--~ 
80.8 13.5 3.8 88.3 8.0 2.2 
44.2 50.0 3.8 I 46.7 48.9 2.2 I 
42.3 53.8 3.8 41.6 55.5 2.2 
40.4 55.8 3.8 41.6 55.5 2.2 
53.8 42.8 I 3.8 ! 46.0 51.0 2.2 
Table 8: Intent to Vaccinate [n, (%)]. 
I ~--- --------~------ -------[ Combined Practices [ 
I For primary immunization of 
children, how many doses of 
vaccine have you been 
recommending 
--~-~----- --~----r-----~ 
0 1 2 >3 
~----~-r-~ 
<6 months 82 3 20 0 (78.1%) (2.9%) (19.2%) (0.0%) 
I 6-23 months 3 8 87 0 (2.3%) (6.35) (91.3eyo) (0.0%) 
----.---.-------------.------~ I-~ 
2-8 years 5 29 87 0 (4.1%) (24.2%) (71.3eyo) (0.0%) 
>8 years 5 104 13 0 --(~:}-~ )--~ (8S.2eyo) (10.7%) (0.0%) 
------,--,_ ... _------_._-----------_._._----_._-.-
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Race: Total No 2nd Dose Percent Odds Ratio 95% C.I. R-value 
White Non-Hispanic 71 25 35.21 1.09 NY 0.991 § 
Other 9 3 33.33 
CME Total No 2nd Dose Percent Odd£Ratio 95% C.I. o-value 
~OHoun 38 10 26.32 
<49 Hours 30 13 43.33 2.14 0.63~OR <4.27 0.141 
CME On-Line 33 10 30.30 
No CME On-Line 45 17 37.78 1.40 0.51~OR<3.07 0.715 
Clinical Practices Total No 2nd Dose Percent Odds Ratio 95%C.I. o-value 
Electronic Medical Record 57 19 33.33 0.3~OR <2.90 0.432 
-y 
Electronic Medical 16 5 31.25 0.91 Record-N 
Vaccine Tracking-Y 37 15 40.54 0.33~OR<I.86 0.412 
Vaccine Tracking-N 41 13 31.71 0.68 
Vaccine Reminders - Y 24 9 37.50 0.37~OR <2.37 0.743 
Vaccine Reminden - N 54 19 35.19 0.90 
Vaccine Stand Orders - Y 28 17 60.71 0.3~OR <1.49 0.375 
Vaccine Stand Orden - N 49 20 40.82 0.45 
Vaccine Clinics - Y 47 17 36.17 0.36~OR <2.20 0.849 
Vaccine Clinics - N 31 10 32.26 0.84 
Table 12 Continued 
48 
Knowledge Total No 2nd Dose Percent Odds Ratio 95% C.1. D-value 
PedIFlu* - Y 45 16 35.56 
PedlFlu· - N 30 11 36.67 1.05 0.42:s0R <2.53 0.922 
Attitudes Total No 2nd Dose Percent Odds Ratio 95% C.I. D-value 
Routine Immunization 76 27 35.53 NV NV NV Part of Practice - Y 
Routine Immunization 0 0 Part of Practice - Other 
Flu shot Last Yr 76 27 35.53 NV 0.667 § 
No Shot Last Yr 4 1 25.00 0.60 
• Ped Flu: Is influenza infection more common in children than in adults? 
§ Fischer's exacttest 
NV Not valid 
49 
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Appendix I 
Quantitative Survey 
Survey of Influenza Vaccine Utilization for 6-23 month old infants 
Sample Letter 
Dear Doctor; 
University of Connecticut Health Center 
School of Medicine 
We are conducting a voluntary survey of physician'S use of Influenza vaccination in 
the 6-23 month old age group. The purpose of the study is to detennine factors that would 
facilitate or hinder the use of vaccine in this age group. It is our hope that this infonnation 
will help improve vaccine utilization by identifying barriers to vaccination. The survey 
consists of a series of questions. Most of the questions are self-explanatory and require 
only one answer. Instructions are inserted in areas that might need clarification. Some 
questions will use a scale of 1 to 5 with 1 being worst and 5 being best. The survey will 
take about 10 minutes or less to complete. 
This is a voluntary survey. You are free not to answer any questions that you don't 
wish to answer. By returning this survey you are consenting to participate in the survey. 
We encourage you to participate and to answer as may questions as possible to increase 
the validity of the survey results. We will not be recording any personal infonnation in 
association with your response - it will be anonymous. Once your response is received all 
personal identifying data will be removed. All infonnation provided to us will be kept 
confidential and no personal data released. This survey is being supported in part by the 
Department of Public Health Immunizations Program and the aggregate results will be 
shared with it. 
We have provided an addressed stamped envelope to return the survey. The return 
envelope has a unique number on it that enables us to identify that you returned the 
survey so that we will not send you a second one. We would like to thank you in advance 
for your participation. If you have questions or concerns regarding the survey, do not 
hesitate to give me a call. 
1 
Sincerely yours; 
John D. Shanley, M.D. 
ProfessorlDirector 
Division of Infectious Diseases 
L2060 
University of Connecticut Health Center 
263 Fannington Ave. 
Fannington, Ct 06030-3212 
860-679-4700 
860-679-4701 FAX 
Jshanley@NS01.UCHC.EDU 
11 
Survey of Influenza Vaccine Utilization for 6-23 month old infants 
Do you currently provide routinely recommended childhood vaccines and/or influenza 
vaccine to any patients in your practice? (Circle one): Y N 
If Yes, please continue and complete the questionnaire. If No, please stop, and return the 
questionnaire in the enclosed stamped and preaddressed envelope. 
1. Are you Male Female 
2. Current age: __ _ 
3. Ethic group (Circle all that apply): 
African American Asian 
Hispanic Native American 
Pacific Islander Multiracial 
4. Year of graduation Medical School: ___ _ 
White (non-hispanic) 
Native Alaskan 
Other 
5. Years of postdoctoral training to first certification (e.g. Pediatrics, Family Practice): 
6. Certification (Circle one): Pediatrics Family Practice 
7. Subspecialty (Circle one): Y N 
8. If yes, please specify: _______ _ 
9. Do you regularly participate in CME category I (Circle one): 
10. If yes, approximate number of CME I hours last year: __ _ 
II. Do you subscribe to medical journals: (Circle one): 
12. Do you participate in CME on-line: (Circle one): 
Y N 
Y N 
Y N 
13. Can the parenteral influenza vaccine cause influenza infection? (Circle one) 
Y N DK (don't know) 
14. Is the influenza vaccine usually effective in preventing influenza? (Circle one) 
Y N DK 
15. Should health care workers receive the influenza vaccine each year? (Circle one) 
Y N 
16 As a health care worker, do you feel you are at risk to get influenza? (Circle one) 
Y N 
111 
17. Can health care workers spread influenza to their patients? (Circle one) 
Y N DK 
18. How contagious is influenza? (Circle one) 
Very Somewhat Minimally 
19.18 influenza infection more common in children than in adults? (Circle one) 
Y N DK 
20. Do you offer annual Influenza vaccination to at least some of your patients? (Circle 
one): Y N 
21. Do you recommend annual Influenza vaccination for at least some of your patients? 
(Circle one): Y N 
22. What months do you generally offer Influenza vaccination? (Circle all that apply) 
Jan Feb Mar Apr May Jun Jul Aug 
Sept Oct Nov Dec 
23. For which of the following age groups do you offer influenza vaccine to all in that 
age group? (Circle all that apply) 
None <6 months 
6-10 years 
6-23 months 
II-IS years 
2-5 years 
>15 years 
24. For primary immunization of children, how many doses of vaccine have you been 
recommending? 
(Circle one) 
<6months 1 2 3 >3 NA 
6-23 months 1 2 3 >3 NA 
2-8 years 1 2 3 >3 NA 
>8 years 1 2 3 >3 NA 
25. Nationally, 2 doses are recommended for primary immunization of 6-23 month olds. 
a. Were you aware of these recommendations? Y N 
b. If yes, please estimate what percentage of 6-23 month olds in your practice who 
received a first dose this past influenza season were also given a second dose (circle one): 
NA 0% 1-9% 10-24% 25-49% 50% or more 
25. Do you think immunization for Influenza is an effective health care tool? 
IV 
1 2 3 4 5 
Disagree Agree 
26. Do you consider Influenza vaccine generally safe? 
1 2 3 4 5 
Disagree Agree 
27. Do you think influenza vaccine commonly causes serious side-effects? 
1 2 3 4 5 
Disagree Agree 
28. Do you think routine immunization of your patients should be part of medical 
practice? 
1 2 
Disagree 
3 4 5 
Agree 
29. Did you receive an Influenza vaccination last year? (Circle one): 
30. If you were vaccinated, check all the reasons that apply: 
Protect myself 
Protect my patients 
Set a good example 
31. If you did not receive vaccination, check all the reasons that apply: 
Don't need one 
Don't think they work 
Forgot 
Worried about side-effects __ 
32. Do you think Influenza vaccine is effective in preventing Influenza 
1 2 3 4 5 
Disagree Agree 
Y N 
33. Do you offer immunization for Influenza to your office staff? (Circle one): Y N 
34. Which of the following best describes your current medical practice (Circle one) 
Solo practice Community Health Clinic 
Single partner AcademiclUniversity 
Group practice Hospital based 
v 
HMOIPPO Other (Specify) 
35. Practice type: (Circle one) Pediatrics Family Medicine Other 
36. Practice location (Circle one): Rural Suburban Urban Other 
37. Estimate the hours per week you work (Circle one): 
<8 8-16 17-24 25-33 33-40 >40 
38. Estimate the percent of your patients in each age range (%) 
<2 
2-10 
11-20 
21-64 
>65 
39. Estimate the ethnic origin of your patient population (%) 
African American 
White (non-hispanic) 
Native American 
Pacific Islander 
Other 
Asian 
Hispanic 
Native Alaskan 
Multiracial 
40. Does your practice use an electronic medical record? (Circle one) 
41. Does your practice use vaccine tracking system? (Circle one) 
42. Does your practice send vaccine reminders? (Circle one) 
Y N 
Y N 
Y N 
43. Does your practice use standing orders for vaccine administration? (Circle one) 
Y N 
44. Does your practice hold vaccine clinics for large scale vaccine administration? (Circle 
~ YN 
45. Estimate the financial mix of your patient population (%) 
Fee for service 
Medicare 
Medicade 
HMOIPPO 
Private insurance 
Town support 
Other 
Thank you for your participation. Please return the survey in the addressed, stamped 
envelope. 
VI 
